Myriad Genetics Says US Patent And Trademark Office Has Granted Patent That Covers Use Of Push-Button Blood Collection Devices For PCR-Based Fetal Sex Determination
Myriad Genetics Says US Patent And Trademark Office Has Granted Patent That Covers Use Of Push-Button Blood Collection Devices For PCR-Based Fetal Sex Determination
Myriad Genetics表示，美國專利商標局已授予專利，涵蓋使用按鈕式血液採集設備進行基於PCR的胎兒性別測定
U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad's SneakPeek Snap products in the U.S through 2040.
美國專利號 11,932,907，標題爲 使用上臂毛細血管血確定胎兒的性別， 在 2040 年之前爲美國的 Myriad 的 SneakPeek Snap 產品提供保護。